Catherine E Mosher1, Mary A Ott, Nasser Hanna, Shadia I Jalal, Victoria L Champion. 1. Author Affiliations: Department of Psychology, Indiana University-Purdue University Indianapolis (Dr Mosher); and Departments of Pediatrics (Dr Ott) and Medicine (Drs Hanna and Jalal), School of Medicine, and School of Nursing (Dr Champion), Indiana University, Indianapolis.
Abstract
BACKGROUND: Little is known about cancer patient and family caregiver preferences for the content and format of nonpharmacologic interventions. Revising interventions based on patient and caregiver feedback before implementation may improve intervention feasibility and acceptability, especially in the context of advanced-stage cancer. OBJECTIVES: The aim of the study was to obtain feedback from patients with advanced-stage, symptomatic lung cancer and their family caregivers on the content and format of a nonpharmacologic symptom management intervention under development. The intervention blended evidence-based cognitive-behavioral and emotion-focused strategies to reduce physical and psychological symptoms. METHODS: Semistructured qualitative interviews were conducted with 21 patients with advanced-stage, symptomatic lung cancer and caregivers. Participants reviewed handouts regarding intervention components and provided feedback. RESULTS: Patients and caregivers desired intervention components that addressed the patient's high symptom burden such as education regarding treatment adverse effects and the provision of various coping tools. Offering interventions with a brief or flexible length and delivering them via telephone were other suggestions for enhancing intervention acceptability. Participants also preferred an equal focus on patient and caregiver concerns and a more positive intervention framework. CONCLUSIONS: Intervention preferences of patients with advanced-stage lung cancer and caregivers underscore the severity of the disease and treatment process and the need to adapt interventions to patients with high symptom burden. These preferences may be incorporated into future intervention trials to improve participant recruitment and retention. IMPLICATIONS FOR PRACTICE: Nurses can modify interventions to meet the needs of patients with advanced-stage, symptomatic lung cancer and caregivers. For example, flexibility regarding intervention content and length may accommodate those with significant symptoms.
BACKGROUND: Little is known about cancerpatient and family caregiver preferences for the content and format of nonpharmacologic interventions. Revising interventions based on patient and caregiver feedback before implementation may improve intervention feasibility and acceptability, especially in the context of advanced-stage cancer. OBJECTIVES: The aim of the study was to obtain feedback from patients with advanced-stage, symptomatic lung cancer and their family caregivers on the content and format of a nonpharmacologic symptom management intervention under development. The intervention blended evidence-based cognitive-behavioral and emotion-focused strategies to reduce physical and psychological symptoms. METHODS: Semistructured qualitative interviews were conducted with 21 patients with advanced-stage, symptomatic lung cancer and caregivers. Participants reviewed handouts regarding intervention components and provided feedback. RESULTS:Patients and caregivers desired intervention components that addressed the patient's high symptom burden such as education regarding treatment adverse effects and the provision of various coping tools. Offering interventions with a brief or flexible length and delivering them via telephone were other suggestions for enhancing intervention acceptability. Participants also preferred an equal focus on patient and caregiver concerns and a more positive intervention framework. CONCLUSIONS: Intervention preferences of patients with advanced-stage lung cancer and caregivers underscore the severity of the disease and treatment process and the need to adapt interventions to patients with high symptom burden. These preferences may be incorporated into future intervention trials to improve participant recruitment and retention. IMPLICATIONS FOR PRACTICE: Nurses can modify interventions to meet the needs of patients with advanced-stage, symptomatic lung cancer and caregivers. For example, flexibility regarding intervention content and length may accommodate those with significant symptoms.
Authors: Laurel L Northouse; Darlene W Mood; Ann Schafenacker; Gregory Kalemkerian; Mark Zalupski; Patricia LoRusso; Daniel F Hayes; Maha Hussain; John Ruckdeschel; A Mark Fendrick; Peter C Trask; David L Ronis; Trace Kershaw Journal: Psychooncology Date: 2012-01-31 Impact factor: 3.894
Authors: Kurt Kroenke; Robert L Spitzer; Janet B W Williams; Patrick O Monahan; Bernd Löwe Journal: Ann Intern Med Date: 2007-03-06 Impact factor: 25.391
Authors: R K Portenoy; H T Thaler; A B Kornblith; J M Lepore; H Friedlander-Klar; E Kiyasu; K Sobel; N Coyle; N Kemeny; L Norton Journal: Eur J Cancer Date: 1994 Impact factor: 9.162
Authors: Ross E O'Hara; Jay G Hull; Kathleen D Lyons; Marie Bakitas; Mark T Hegel; Zhongze Li; Tim A Ahles Journal: Palliat Support Care Date: 2010-09-28
Authors: Erin E Krebs; Karl A Lorenz; Matthew J Bair; Teresa M Damush; Jingwei Wu; Jason M Sutherland; Steven M Asch; Kurt Kroenke Journal: J Gen Intern Med Date: 2009-05-06 Impact factor: 5.128
Authors: Joseph G Winger; Kevin L Rand; Nasser Hanna; Shadia I Jalal; Lawrence H Einhorn; Thomas J Birdas; DuyKhanh P Ceppa; Kenneth A Kesler; Victoria L Champion; Catherine E Mosher Journal: J Pain Symptom Manage Date: 2018-01-31 Impact factor: 3.612
Authors: Daiming Xiu; Yat-Lui Fung; Bobo Hi-Po Lau; Daniel F K Wong; Celia H Y Chan; Rainbow T H Ho; Tsz-Him So; Tai-Chung Lam; Victor Ho-Fun Lee; Anne W M Lee; Sau Fong Chow; Fai Man Lim; Miu Wah Tsang; Cecilia L W Chan; Amy Y M Chow Journal: Support Care Cancer Date: 2019-07-06 Impact factor: 3.603
Authors: Darryl Somayaji; Amanda C Blok; Laura L Hayman; Yolanda Colson; Michael Jaklisch; Mary E Cooley Journal: Support Care Cancer Date: 2019-01-14 Impact factor: 3.603